ODTX (Odyssey Therapeutics, Inc. Common Stock) Stock Analysis - AI Report
Odyssey Therapeutics, Inc. Common Stock (ODTX) is a publicly traded the market company. As of May 21, 2026, ODTX trades at $16.98 with a market cap of $820.36M and a P/E ratio of 0.00. ODTX moved +0.35% today. Year to date, ODTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.35 to $20.30. Rallies surfaces ODTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on ODTX?
Rallies AI research for ODTX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
TPG GP A, LLC bought 1.39M (~$25.00M) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC sold 1.06K (~$19.17K) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC bought 222.22K (~$4.00M) on May 11, 2026.
ODTX Analyst Consensus
ODTX analyst coverage data. Average price target: $0.00.
Common questions about ODTX
What is the AI research view on ODTX?
Rallies AI research for ODTX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for ODTX?
Rallies AI research for ODTX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is ODTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ODTX. It does not provide personalized investment advice.
